AVEDIAN
Founded 2014 · 2 employees on LinkedIn · 1 known investors
Find your way into AVEDIAN
271 people in our graph share verified history with the AVEDIAN team — schools, employers, funds. One of them is your warm intro.
Eliza Cushmanunlockedknows Guillermo Tabares Martinez · together at Columbia Business School (overlapped)
×2knows the team · via Columbia Business School
×9knows the team · via Babson F.W. Olin Graduate School of Business
Avedian builds AI-powered software modules for hospitals, clinics, health insurers, and pharmaceutical companies to manage clinical operations, economic performance, data governance, and risk-sharing agreements. The platform serves Latin American healthcare organizations seeking to optimize clinical delivery, control costs, and automate administrative processes.
Founders & leadership
AVEDIAN was founded in 2014 by Guillermo Tabares Martinez.
GT
Guillermo Tabares MartinezinCofounder & CEOGuillermo Tabares Martinez is a physician with expertise in population health, patient classification systems, and data science applications in healthcare. He is founder and CEO of Avedian, which develops AI-powered software for hospitals, health insurers, and pharmaceutical companies to manage clinical operations, costs, and risk-sharing arrangements across Latin America and beyond.
Investors · 1
Competitors · 1
by search overlapCompanies competing with AVEDIAN for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does AVEDIAN do?
- Avedian builds AI-powered software modules for hospitals, clinics, health insurers, and pharmaceutical companies to manage clinical operations, economic performance, data governance, and risk-sharing agreements. The platform serves Latin American healthcare organizations seeking to optimize clinical delivery, control costs, and automate administrative processes.
- Who founded AVEDIAN?
- AVEDIAN was founded by Guillermo Tabares Martinez in 2014.
- Who are AVEDIAN's investors?
- AVEDIAN's investors include FJ Labs.



